|
|
.
See Category: Neoplasms
See Header: Intraductal carcinoma in situ of breast
ICD-10 (CM) Code and Descriptor
|
D05.11 |
Intraductal carcinoma in situ of right breast
|
D0511 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 63.26%
|
21.30%
|
6.54%
|
3.26%
|
1.79%
|
1.12%
|
0.78%
|
0.60%
|
0.41%
|
0.25%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D05.11*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
20,934
|
21,049
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
11,838
|
11,873
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
8,286
|
14,948
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
6,815
|
6,847
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
6,621
|
6,624
|
|
80053
|
COMPREHEN METABOLIC PANEL |
6,404
|
6,404
|
|
J3010
|
FENTANYL CITRATE INJECTION |
6,332
|
10,286
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
6,153
|
200,821
|
|
J2405
|
ONDANSETRON HCL INJECTION |
5,892
|
26,057
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
5,755
|
9,864
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
5,223
|
20,892
|
|
19301
|
PARTIAL MASTECTOMY |
4,914
|
4,914
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
4,911
|
6,628
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
4,734
|
4,734
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
4,419
|
30,261
|
|
77065
|
DX MAMMO INCL CAD UNI |
3,947
|
3,952
|
|
76098
|
X-RAY EXAM SURGICAL SPECIMEN |
3,880
|
4,119
|
|
88360
|
TUMOR IMMUNOHISTOCHEM/MANUAL |
3,809
|
7,697
|
|
A4648
|
IMPLANTABLE TISSUE MARKER |
3,733
|
4,514
|
|
77066
|
DX MAMMO INCL CAD BI |
3,644
|
3,644
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D05.11 related to the following DRG Codes:
582-583
597-599
|
